Research ArticleSpecial Section on Transporters in Toxicity and Disease
The Major Facilitative Folate Transporters Solute Carrier 19A1 and Solute Carrier 46A1: Biology and Role in Antifolate Chemotherapy of Cancer
Larry H. Matherly, Mike R. Wilson and Zhanjun Hou
Drug Metabolism and Disposition April 2014, 42 (4) 632-649; DOI: https://doi.org/10.1124/dmd.113.055723
Larry H. Matherly
Department of Oncology (L.H.M., M.R.W., Z.H.) and Department of Pharmacology (L.H.M.), Wayne State University School of Medicine, Detroit, Michigan; and Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan (L.H.M., Z.H.)
Mike R. Wilson
Department of Oncology (L.H.M., M.R.W., Z.H.) and Department of Pharmacology (L.H.M.), Wayne State University School of Medicine, Detroit, Michigan; and Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan (L.H.M., Z.H.)
Zhanjun Hou
Department of Oncology (L.H.M., M.R.W., Z.H.) and Department of Pharmacology (L.H.M.), Wayne State University School of Medicine, Detroit, Michigan; and Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan (L.H.M., Z.H.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleSpecial Section on Transporters in Toxicity and Disease
Biology and Therapy of Facilitative Folate Transporters
Larry H. Matherly, Mike R. Wilson and Zhanjun Hou
Drug Metabolism and Disposition April 1, 2014, 42 (4) 632-649; DOI: https://doi.org/10.1124/dmd.113.055723
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement